Bri'Anna Horne, Henry Badji, Md Taufiqur Rahman Bhuiyan, Lucero Romaina Cachique, Jennifer Cornick, Aneeta Hotwani, Jane Juma, John Benjamin Ochieng, Mahamadou Abdou, Evans Apondi, Hannah E Atlas, Alex O Awuor, Kate S Baker, Bubacarr E Ceesay, Mary Charles, Nigel A Cunliffe, Erika Feutz, Sean R Galagan, Ibrehima Guindo, M Jahangir Hossain, Junaid Iqbal, Fatima Jallow, Noumou Yakhouba Keita, Farhana Khanam, Karen L Kotloff, Victor Maiden, Katia Manzanares Villanueva, Oscar Mito, Md Parvej Mosharraf, Joseph Nkeze, Usman N Ikumapayi, Maribel Paredes Olortegui, Patricia B Pavlinac, Tackeshy Pinedo Vasquez, Firdausi Qadri, Farah Naz Qamar, Sonia Qureshi, Nazia Rahman, Aminata Sangare, Sunil Sen, Pablo Peñataro Yori, Mohammad Tahir Yousafzai, Dilruba Ahmed, Khuzwayo C Jere, Margaret N Kosek, Richard Omore, Jasnehta Permala-Booth, Ousman Secka, Sharon M Tennant
BACKGROUND: Shigella is a major cause of diarrhea in young children worldwide. Multiple vaccines targeting Shigella are in development, and phase 3 clinical trials are imminent to determine efficacy against shigellosis. METHODS: The Enterics for Global Health (EFGH) Shigella surveillance study is designed to determine the incidence of medically attended shigellosis in 6- to 35-month-old children in 7 resource-limited settings. Here, we describe the microbiological methods used to isolate and identify Shigella ...
March 2024: Open Forum Infectious Diseases